Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

First pregnancies reported using a new, needle-free device for administering hormones to IVF women

03.07.2002


Fear of needles and the discomfort of daily injections could soon be a thing of the past for women undergoing IVF treatment thanks to a new device which can administer hormones without a needle injection.



Dr Stuart Lavery, a Subspeciality Fellow in Reproductive Medicine and Surgery at the Hammersmith Hospital in London, UK, told the European Society of Human Reproduction and Embryology conference in Vienna today (Wednesday 3 July) that a team at the hospital had achieved the first pregnancies using the needle-free device which is called a J-Tip.

To retrieve eggs from the ovary of a woman undergoing IVF treatment, doctors have to stimulate the ovaries to go into overdrive and produce several follicles (groups of cells) containing the eggs. They do this by injecting hormones into the woman over a period of time before they perform the operation to retrieve the follicles. For women who are "needle-phobic" the regular injections can be a problem.


The J-Tip is a single-use, disposable device, capable of delivering a liquid therapeutic agent under the skin. It is about 10 cms long and it works by using a compressed carbon dioxide gas cartridge to propel the medication, under high pressure, through the skin into the subcutaneous layer below. The high pressure enables the medication itself to pierce the skin, thereby avoiding the use of a needle.

The team led by Mr Geoffrey Trew, a consultant gynaecologist at the Hammersmith, tested the J-Tip on 20 patients between the ages of 20 and 38 years old, who were undergoing IVF treatment, to see how effective it was in prompting controlled ovarian hyperstimulation. They also wanted to test how easy it was to use, how acceptable it was to the patients and whether its use could result in pregnancies.

Nurses used the J-Tip to deliver recombinant follicle stimulating hormone (Puregon NV Organon) to the women once a day for an average of 10 days. Subsequently the researchers were able to retrieve an average of 12 eggs each from 16 of the 20 women. The treatment of one patient was cancelled due to poor response, one was cancelled due to the number of technically incorrect J-Tip injections, and two women asked to withdraw from the study. As a result of successful egg collection, four of the women then became pregnant.

Dr Lavery said: "The results in this small study were reassuringly comparable with conventional techniques in terms of number of eggs collected and pregnancy rates. This is the first time that the J-Tip has been used in reproductive medicine and we can report the first pregnancies achieved using this system. The study shows that the J-Tip is capable of delivering hormones in a new and less invasive way.

"The development of a needle-free injection system is an important target in the improvement of patient convenience in IVF, where the drug treatment phase can require daily injections for several weeks, which for many can be a stressful experience, particularly for those who have a fear of needles. Although nurses administered the J-Tip injections, the ultimate aim is for the patients to be able to do it themselves. Diaries kept by patients during their treatment indicated a high level of patient acceptance of the J-Tip. All the women had undergone conventional IVF cycles previously and their diaries indicate a clear preference for the needle-free approach."


Abstract no: O-203 (Wednesday 10.00hrs CET Hall A) URL: http://conf.eshre.com/PDF/O-203.pdf

Note: A costing on the J-Tip device is still in development.

Further information:
Margaret Willson, information officer
Tel: +44 (0) 1536 772181
Fax: +44 (0) 1536 77219
Mobile: +44 (0) 7973 853 347
Email: m.willson@mwcommunications.org.uk

Emma Mason, information officer
Tel: +44 (0) 1376 563090
Fax: +44 (0) 1376 563272
Mobile: +44 (0) 7711 296 986
Email: wordmason@aol.com

Press Office: (Sunday 30 June – Wednesday 3 July)
Margaret Willson, Emma Mason, Janet Blümli
Tel: +43 (0) 1 260 69 2010 or
+43 (0) 1 260 69 2011
Fax: +43 (0) 1 260 69 2012


Emma Mason | EurekAlert!
Further information:
http://conf.eshre.com/PDF/O-203.pdf

More articles from Health and Medicine:

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

nachricht Study advances gene therapy for glaucoma
17.01.2018 | University of Wisconsin-Madison

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>